# Evaluating the Combined Effect of Vedolizumab and Semi-Vegetarian Diet on Ulcerative Colitis.

> **NCT03309865** · EARLY_PHASE1 · WITHDRAWN · sponsor: **Mayo Clinic**

## Conditions studied

- Ulcerative Colitis
- Dietary Modification

## Interventions

- **DIETARY_SUPPLEMENT:** semi-vegetarian diet
- **DRUG:** Vedolizumab Injection

## Key facts

- **NCT ID:** NCT03309865
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-12-25
- **Primary completion:** 2018-08-31
- **Final completion:** 2018-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Not enough patients to enroll.
- **Last updated:** 2018-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03309865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03309865, "Evaluating the Combined Effect of Vedolizumab and Semi-Vegetarian Diet on Ulcerative Colitis.". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03309865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*